NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 105 filers reported holding NURIX THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,042,957 | +1382.4% | 49,974 | +944.2% | 0.00% | – |
| Q1 2024 | $70,354 | -13.0% | 4,786 | -38.9% | 0.00% | – |
| Q4 2023 | $80,857 | -76.9% | 7,835 | -82.4% | 0.00% | -100.0% |
| Q3 2023 | $350,438 | -31.3% | 44,585 | -12.7% | 0.00% | 0.0% |
| Q2 2023 | $510,099 | +18.9% | 51,061 | +5.7% | 0.00% | 0.0% |
| Q1 2023 | $429,037 | -20.5% | 48,315 | -1.7% | 0.00% | 0.0% |
| Q4 2022 | $539,788 | -12.5% | 49,161 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $617,000 | +3.0% | 47,323 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $599,000 | +40.6% | 47,246 | +55.6% | 0.00% | 0.0% |
| Q1 2022 | $426,000 | -56.4% | 30,372 | -10.1% | 0.00% | 0.0% |
| Q4 2021 | $978,000 | -2.0% | 33,799 | +1.5% | 0.00% | 0.0% |
| Q3 2021 | $998,000 | -12.9% | 33,312 | -22.9% | 0.00% | 0.0% |
| Q2 2021 | $1,146,000 | +2.0% | 43,188 | +19.6% | 0.00% | 0.0% |
| Q1 2021 | $1,123,000 | +94.0% | 36,111 | +104.9% | 0.00% | 0.0% |
| Q4 2020 | $579,000 | -1.4% | 17,620 | +4.8% | 0.00% | 0.0% |
| Q3 2020 | $587,000 | – | 16,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,422,549 | $90,800,000 | 15.85% |
| Ponoi II Management, LLC | 686,274 | $18,207,000 | 14.76% |
| Ponoi Management, LLC | 686,274 | $18,207,000 | 10.12% |
| Foresite Capital Management V, LLC | 451,522 | $11,979,000 | 4.71% |
| Foresite Capital Management IV, LLC | 1,205,798 | $31,990,000 | 4.32% |
| Bain Capital Life Sciences Investors, LLC | 1,284,314 | $34,073,000 | 2.23% |
| EcoR1 Capital, LLC | 1,967,950 | $52,210,000 | 1.95% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 571,212 | $15,155,000 | 1.93% |
| DAFNA Capital Management LLC | 306,320 | $8,127,000 | 1.70% |
| Euclidean Capital LLC | 154,426 | $4,097,000 | 1.33% |